ResMed | RMD - Ordinary Share Capital


ResMed reported $145.06M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Ansell USD 142.94M 885.26M Dec/2025
Artivion USD 47.84M 468K Dec/2025
AtriCure USD 50.64M 7K Jun/2026
Baxter International USD 517M 549K Jun/2026
Cochlear AUD 65.4M 1.12B Dec/2025
Cooper Companies USD 195.11M 14K Mar/2026
CSL USD 482.13M 93.87M Dec/2025
Dexcom USD 377.4M 8.5M Jun/2026
Edwards Lifesciences USD 577M 3.7M Mar/2026
Fisher Paykel Healthcare NZD 586.94M 313.22K Jun/2026
Globus Medical USD 135.67M 611K Mar/2026
Haemonetics USD 45.47M 1.36M Jun/2026
Idexx Laboratories USD 78.87M 366K Jun/2026
Inogen USD 23K 0 Dec/2023
Insulet USD 69.35M 87K Jun/2026
Integra LifeSciences USD 77.78M 39K Jun/2026
Intuitive Surgical USD 354.16M 1.01M Jun/2026
Medtronic USD 1.28B 3.19M Mar/2026
Philips EUR 952.02M 729K Mar/2026
Ramsay Health Care AUD 229.93M 29.81K Dec/2025
ResMed USD 145.06M 45.78M Jun/2026
Sigma Healthcare AUD 11.5B 9.93B Dec/2025
Sonic Healthcare AUD 4.15B 467K Dec/2024
Steris USD 98.07M 72K Mar/2026
Teleflex USD 44.26M 70K Mar/2026
Thermo Fisher Scientific USD 371.62M 1000 Jun/2026